Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 to 80

Examining brain function in laryngeal dystonia and voice tremor

Official title: Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor

Run by Massachusetts Eye and Ear Infirmary · NCT05216770 · Data updated 2026-11-12

This study is testing how brain function differs in people with laryngeal dystonia and voice tremor compared to healthy individuals to better understand these voice disorders.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment165 (estimated)
SponsorMassachusetts Eye and Ear Infirmary
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedMarch 24, 2022
Main results expectedAugust 31, 2027
Study endsAugust 31, 2027
Registry record updatedDecember 2, 2025
Trial IDNCT05216770 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include right-handed individuals aged 18-80 with a diagnosis of laryngeal dystonia or voice tremor.

Probably not a fit

Patients with neurological or psychiatric disorders unrelated to laryngeal dystonia or voice tremor may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the neural mechanisms underlying laryngeal dystonia and voice tremor using advanced brain imaging techniques. By comparing the functional neural correlates of these two voice disorders, the researchers aim to identify specific pathophysiological features that differentiate them. The study includes both patients with these disorders and healthy controls to provide a comprehensive understanding of the central nervous system's role in speech production. The approach combines multimodal imaging to capture both spatial and temporal aspects of brain activity during phonation.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic and therapeutic strategies for individuals suffering from laryngeal dystonia and voice tremor.

How similar studies have gone: While there have been studies on voice disorders, this specific multimodal approach to understanding the neural pathophysiology of laryngeal dystonia and voice tremor is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. Males and females of diverse racial and ethnic background;
2. Age 18-80 years;
3. Native English speakers;
4. Right-handed;
5. Normal cognitive status;
6. Patients will have laryngeal dystonia or voice tremor;
7. Healthy controls will be healthy individuals without neurological, psychiatric or otolaryngological problems.

Exclusion criteria:

1. Subjects who are incapable of giving informed consent;
2. Pregnant or breastfeeding women until a time when they are no longer pregnant or breastfeeding. All women of childbearing potential will have a urine pregnancy test performed before MRI, which must be negative for participation in the imaging studies;
3. Subjects with a past or present medical history of (a) neurological problems, such as stroke, movement disorders (other than specified LD and VT in the patient groups), brain tumors, traumatic brain injury with loss of consciousness, ataxias, myopathies, myasthenia gravis, demyelinating diseases; (b) psychiatric problems, such as schizophrenia, bipolar depression, obsessive-compulsive disorder, alcoholism, drug dependence; (c) laryngeal problems, such as vocal fold paralysis, paresis, vocal fold nodules and polyps, carcinoma, chronic laryngitis;
4. Patients with any other form of dystonia;
5. Patients who have dystonia symptoms at rest or have a presence of mirror dystonia;
6. Patients who are not symptomatic due to treatment with botulinum toxin injections into the affected muscles. The duration of positive effects of botulinum toxin varies from patient to patient but lasts, on average, for 3-4 months. All patients will be evaluated to ensure that they are fully symptomatic and are at least 3 months post-injection before participation;
7. To avoid the confounding effect of centrally acting drugs, all study participants will be questioned about any prescribed or over-the-counter medications as part of their initial screening. Those patients who receive medication(s) affecting the central nervous system will be excluded;
8. Patients will be asked whether they have undergone any head or neck surgery, which resulted in changes in regional anatomy or innervation. Because brain or laryngeal surgery may potentially lead to brain structure and function re-organization, all patients with such a history will be excluded;
9. Subjects who have certain tattoos and ferromagnetic objects in their bodies (e.g., implanted stimulators, surgical clips, prosthesis, artificial heart valve) that cannot be removed for MRI studies.

Where it's running

  • Massachusetts Eye and Ear and University of California San Francisco
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.